Web Results

www.ncbi.nlm.nih.gov/pmc/articles/PMC3551962

Jan 22, 2013 ... In Hurwitz et al; [7] the chemotherapy regimen used was IFL, known to be a toxic regimen and now rarely used whereas Saltz et al; [8] added ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3336830

Apr 3, 2012 ... and Herbert I. Hurwitz. Duke University ..... In a pooled analysis of two placebo- controlled studies, Kabbinavar et al. [73] evaluated clinical ...

www.ncbi.nlm.nih.gov/pubmed/23881988

Jul 23, 2013 ... Hurwitz HI(1), Tebbutt NC, Kabbinavar F, Giantonio BJ, Guan ZZ, ... by treatment ( chemotherapy with or without placebo vs. chemotherapy plus ...

www.ncbi.nlm.nih.gov/pubmed/15908660

May 20, 2005 ... Hurwitz HI(1), Fehrenbacher L, Hainsworth JD, Heim W, Berlin J, Holmgren E, Hambleton J, Novotny WF, Kabbinavar F. Author information:

www.ncbi.nlm.nih.gov/pmc/articles/PMC3273357

Jan 12, 2012 ... Stratification factors were age (⩽65 years vs >65 years), extent of metastatic ... Based on the results of the BICC trial (Fuchs et al, 2007) the study was .... of irinotecan plus fluoropyrimidines and Bev (Hurwitz et al, 2004). Thus ...